Inhibitor receptorii angiotensini II

Inhibitores receptorii angiotensini II ad systematem renini-angiotensini-aldosteroni (SRAA) efficacem sunt.

Inhibitores receptorii angiotensini II vel antagonistae receptori AT1 vel brevius sartani sunt grex medicamentorum cum effectibus praecipue antihypertensivis, qui ad systematem renini-angiotensini-aldosteroni efficacem contra hypertensionem arterialis sunt.[1] Cunctorum inhibitorum receptorii angiotensini II Codex ATC est C09CA.

Effectibus similes sunt inhibitores enzymi angiotensinum convertentes, qui non angiotensini II receptoria obsident sed enzymum angiotensinum II formantem. Verbis aliis: Inhibitores enzymi angiotensinum convertentis prae angiotensinum II, verum hi inhibitores receptorii angiotensini II post angiotensinum II agunt.

  1. Higuchi S, Ohtsu H, Suzuki H, Shirai H, Frank GD, Eguchi S (Aprilis 2007). "Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology". Clin Sci 112: 417–28 .

From Wikipedia, the free encyclopedia · View on Wikipedia

Developed by Nelliwinne